Literature DB >> 3032218

Structure of the O-chain of the lipopolysaccharide of Haemophilus pleuropneumoniae serotype 1.

E Altman, J R Brisson, M B Perry.   

Abstract

By phenol-water extraction an aqueous-phase soluble cellular lipopolysaccharide was isolated from Haemophilus pleuro-pneumoniae serotype 1. It was shown by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, hydrolysis, methylation, and both one- and two-dimensional 1H and 13C nuclear magnetic resonance studies to be an S-type lipopolysaccharide, which could be cleaved to yield a lipid A and an O-chain polysaccharide identified as a high molecular weight branched polymer of a tetrasaccharide repeating unit having the structure: (Formula: see text).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3032218     DOI: 10.1139/o86-173

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  5 in total

1.  Pathogenesis of porcine Actinobacillus pleuropneumonia: Part I. Effects of surface components of Actinobacillus pleuropneumoniae in vitro and in vivo.

Authors:  H Huang; A A Potter; M Campos; F A Leighton; P J Willson; W D Yates
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

Review 2.  ABC transporters involved in export of cell surface glycoconjugates.

Authors:  Leslie Cuthbertson; Veronica Kos; Chris Whitfield
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

Review 3.  Surface polysaccharides and iron-uptake systems of Actinobacillus pleuropneumoniae.

Authors:  Mario Jacques
Journal:  Can J Vet Res       Date:  2004-04       Impact factor: 1.310

4.  Lipopolysaccharides of Actinobacillus pleuropneumoniae bind pig hemoglobin.

Authors:  M Bélanger; C Bégin; M Jacques
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

5.  Surface Polysaccharide Mutants Reveal that Absence of O Antigen Reduces Biofilm Formation of Actinobacillus pleuropneumoniae.

Authors:  S Hathroubi; M A Hancock; J T Bossé; P R Langford; Y D N Tremblay; J Labrie; M Jacques
Journal:  Infect Immun       Date:  2015-10-19       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.